Financhill
Buy
74

MKKGY Quote, Financials, Valuation and Earnings

Last price:
$29.94
Seasonality move :
-0.9%
Day range:
$29.92 - $30.31
52-week range:
$24.32 - $31.80
Dividend yield:
1.67%
P/E ratio:
19.85x
P/S ratio:
2.77x
P/B ratio:
6.44x
Volume:
65.4K
Avg. volume:
102.6K
1-year change:
1.32%
Market cap:
$65.1B
Revenue:
$22.9B
EPS (TTM):
$1.51

Analysts' Opinion

  • Consensus Rating
    Merck KGaA has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $34.04, Merck KGaA has an estimated upside of 13.69% from its current price of $29.94.
  • Price Target Downside
    According to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $29.94.

Fair Value

  • According to the consensus of 1 analyst, Merck KGaA has 13.69% upside to fair value with a price target of $34.04 per share.

MKKGY vs. S&P 500

  • Over the past 5 trading days, Merck KGaA has overperformed the S&P 500 by 3.46% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Merck KGaA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Merck KGaA has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Merck KGaA reported revenues of $6.2B.

Earnings Growth

  • Merck KGaA has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Merck KGaA reported earnings per share of $0.48.
Enterprise value:
76.7B
EV / Invested capital:
--
Price / LTM sales:
2.77x
EV / EBIT:
15.44x
EV / Revenue:
3.26x
PEG ratio (5yr expected):
1.65x
EV / Free cash flow:
207.74x
Price / Operating cash flow:
176.20x
Enterprise value / EBITDA:
10.80x
Gross Profit (TTM):
$13.8B
Return On Assets:
5.89%
Net Income Margin (TTM):
13.96%
Return On Equity:
10.11%
Return On Invested Capital:
7.45%
Operating Margin:
22.9%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $22.9B $22.7B $23.5B $5.8B $6.2B
Gross Profit $13.7B $13.3B $13.8B $3.5B $3.8B
Operating Income $5B $4.7B $5B $1.4B $1.4B
EBITDA $7B $7B $7.1B $1.9B $2B
Diluted EPS $1.42 $1.35 $1.51 $0.41 $0.48
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $12B $12.7B $14.4B $15.5B $15.1B
Total Assets $50.8B $49.9B $52.8B $56B $59.8B
Current Liabilities $11.3B $9.2B $9.2B $11.7B $10.1B
Total Liabilities $26.8B $22.1B $22.9B $24.3B $25.8B
Total Equity $24B $27.8B $30B $31.7B $34.1B
Total Debt $9.5B $9.1B $10.1B $8.8B $12.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $4B $4.7B $4.3B $1.6B $1.8B
Cash From Investing -$1.8B -$3.1B -$4.8B -$1.8B -$3.5B
Cash From Financing -$1.3B -$752.7M -$409.8M $787.3M $3B
Free Cash Flow -$1.6B $577.7M $369.4M -$646.5M $579.8M
MKKGY
Sector
Market Cap
$65.1B
$28.1M
Price % of 52-Week High
94.15%
51.87%
Dividend Yield
1.67%
0%
Shareholder Yield
0.97%
-1.59%
1-Year Price Total Return
1.32%
-17.31%
Beta (5-Year)
0.974
0.495
Dividend yield:
1.67%
Annualized payout:
$0.47
Payout ratio:
-36.39%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $29.28
200-day SMA
Buy
Level $26.60
Bollinger Bands (100)
Buy
Level 25.51 - 28.09
Chaikin Money Flow
Buy
Level 7.9M
20-day SMA
Buy
Level $28.63
Relative Strength Index (RSI14)
Buy
Level 69.93
ADX Line
Buy
Level 16.76
Williams %R
Sell
Level -13.5531
50-day SMA
Buy
Level $27.42
MACD (12, 26)
Buy
Level 0.64
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level 5.5M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.9963)
Buy
CA Score (Annual)
Level (0.3628)
Buy
Beneish M-Score (Annual)
Level (-2.7171)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.9974)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Stock Forecast FAQ

In the current month, MKKGY has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MKKGY average analyst price target in the past 3 months is $34.04.

  • Where Will Merck KGaA Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Merck KGaA share price will rise to $34.04 per share over the next 12 months.

  • What Do Analysts Say About Merck KGaA?

    Analysts are divided on their view about Merck KGaA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merck KGaA is a Sell and believe this share price will drop from its current level to $34.00.

  • What Is Merck KGaA's Price Target?

    The price target for Merck KGaA over the next 1-year time period is forecast to be $34.04 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MKKGY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Merck KGaA is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of MKKGY?

    You can purchase shares of Merck KGaA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merck KGaA shares.

  • What Is The Merck KGaA Share Price Today?

    Merck KGaA was last trading at $29.94 per share. This represents the most recent stock quote for Merck KGaA. Yesterday, Merck KGaA closed at $29.94 per share.

  • How To Buy Merck KGaA Stock Online?

    In order to purchase Merck KGaA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Amkor Stock Up So Much?
Why Is Amkor Stock Up So Much?

Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock